Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.4.24.11 (
CD10
)
9,792
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
In Indonesia, 107 women requesting insertion of the contraceptive implant system
Norplant
at the Klinik Raden Saleh in Jakarta kept a daily menstrual diary for 90 days before endometrial biopsy and allowed venous blood samples to be taken six times in the two-week period also before endometrial biopsy so researchers could examine the roles of endothelin (ET) and
neutral endopeptidase
(
NEP
) in menstrual bleeding changes in women using
Norplant
. They compared the degree of immunostaining in the endometrial biopsy samples of these women with those of 55 controls, most of which came from women in Melbourne, Australia. The endometrium of the
Norplant
group exhibited low glandular and luminal epithelial ET immunostaining as did the normal endometrium during the proliferative phase. Glandular epithelial ET immunostaining in the
Norplant
group fell considerably during the secretory or menstrual phases, however.
NEP
immunoreactivity was greater in the endometrium of
Norplant
users than in that of controls, suggesting that enzyme activity may have been increased locally among
Norplant
users. This increase may have accounted for the low ET reactivity. ET immunoreactivity was not related to duration of implant use or total number of bleeding days. These findings indicate that, since
Norplant
users are at an increased risk of abnormal uterine bleeding, ET may control menstrual bleeding. It is not known whether ET acts as a mitogen in endometrial repair and regeneration or as a vasoconstrictor to stop bleeding after menstruation.
...
PMID:Immunolocalization of endothelin and neutral endopeptidase in the endometrium of users of subdermally implanted levonorgestrel (Norplant). 856 75